Valence 로고
인기
로그인

관심목록에 추가

LifeMD Inc.

NasdaqGM: LFMDP · 실시간 가격 · USD
23.40
+0.15 (0.65%)
종가 기준: Aug 18, 2026, 9:42 AM

LifeMD Inc. (LFMDP) Stock Price, Analysis & Data

0.65%
매수호가23.45
시가총액n/a
매출 (ttm)191.59M
순이익 (ttm)-24.87M
베타2.06
EPS (ttm)-2.26
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)74.05
P/S (ttm)n/a
Earnings Daten/a
매도호가24
거래량436
평균 거래량 (20일)2,206
시가23.40
전일 종가23.25
일중 범위23.40 - 23.40
52주 범위18.50 - 24.20
애널리스트n/a
목표주가n/a
배당$2.22 (9.54%)
배당락일2026년 7월 2일

LFMDP 소개

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and p...

[더 보기]
산업 Health Information Services
섹터 Healthcare
IPO 일자 Oct 5, 2021
직원 수 347
상장 거래소 NasdaqGM
티커 LFMDP
웹사이트 https://lifemd.com
전체 기업 정보

재무 실적

2025년 LifeMD의 매출은 194.06M로, 전년 154.82M 대비 25.34% 증가했습니다. 순이익은 14.35M로, -167.05% 감소했습니다.

재무제표
news image

6일 전 · Motley Fool

LifeMD (LFMD) Q2 2026 Earnings Call Transcript

Revenue met guidance but profitability targets missed amid strategic restructuring.

news image

1주 전 · Moby

LifeMD, Inc. Q2 2026 Earnings Call Summary

Moby summary of LifeMD, Inc.'s Q2 2026 earnings call

news image

1주 전 · MarketBeat

LifeMD Q2 Earnings Call Highlights

LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer acquisi...

news image

1주 전 · Zacks

LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

LifeMD (LFMD) delivered earnings and revenue surprises of +20.00% and -3.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

2주 전 · MarketBeat

Medifast Q2 Earnings Call Highlights

Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1 medica...

2 페이지 중 1